Home » Newsletters » BioWorld Science

BioWorld Science

May 30, 2014

View Archived Issues

Muscle homing peptide-PMO conjugate shows promise in dystrophin-deficient mice

Novel bispecific anti-VEGF/ANG-2 MAb for the treatment of ocular disorders

Vitamin D supplementation tested for prediabetes progression treatment

Extended-spectrum pleuromutilins tested for efficacy against antimicrobial-resistant infections

Clinical evaluation of a dendritic cell-targeting vaccine for the treatment of refractory tumors

Investigators develop and characterize protein kinase C interaction disruptors

Nonhuman primate efficacy and human safety assessed for agent against Marburg virus

Bristol-Myers Squibb patents novel NS3/NS4A inhibitors for HCV

Novel multipeptide cocktail compositions reported by Dana-Farber Cancer Institute

Bayer Schering Pharma patents novel sGC activators

Researchers at Medeia Therapeutics synthesize novel agents for neurodegenerative disorders

Single-chain insulin analogues disclosed by Case Western Reserve University

Small-molecule Abeta oligomer receptor antagonist reported for Alzheimer's disease

Xencor begins phase Ia study of XmAb-7195 for asthma

Lilly presents novel MOGAT2 inhibitors for hypertriglyceridemia

PolyTherics and Alpha Cancer Technologies establish collaboration

Trimel reports topline phase II results for Tefina

UCB Celltech initiates phase I trial in patients with psoriatic arthritis

FDA accepts for filing Rockwell's NDA for iron replacement therapy

Reata and AbbVie to initiate phase II trial of lotion to prevent radiation dermatitis

Transgene discloses phase IIb data for TG-4010

Tekmira to initiate phase I/II trial of RNAi agent in hepatocellular carcinoma

Dosing under way in phase IIa study of LPCN-1111 in hypogonadal men

OncoCyte and Cornell University collaborate to develop lung cancer diagnostic

Partners in Parkinson's initiative launched by the Michael J. Fox Foundation and AbbVie

Micromedic to develop diagnostic for risk of bisphosphonate-related osteonecrosis of the jaw

Sorafenib gains E.U. approval for thyroid cancer

NDA submission for safinamide for Parkinson's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...